Test yourself and see how you compare with your peers! | Appropriate Assessment and Risk Stratification of UTUC to Inform Treatment Planning | 0.25-hour CME/CE | Clinical Case Challenge #1 of 2 | #MedEd #cme #Urothelialcarcinoma | https://bit.ly/4fws8VN
About us
PRIME Education is a research and education company that advances the science of learning and behavior change among providers, patients, payers, and health ecosystems in order to improve competency, performance, and quality health outcomes. PRIME addresses gaps responsible for variations in care by leveraging real-world data, the latest clinical evidence, and innovative learning models to invoke positive change in health and wellness at the individual, system, and community levels. The scalable and sustainable solutions that PRIME delivers have measurably improved patient care since its founding in 1994. See our latest CME/CE offerings: - https://primeinc.org Learn more about PRIME and contact us: - https://primece.com Leading the industry with over 60 peer-reviewed publications in the last 2 years. Winner of the 2024 William Campbell Felch and Outstanding Outcomes Awards 2021 Awards - ACEhp William Campbell Felch Award for Outstanding Research in CE 2019 Awards - ACEhp William Campbell Felch Award for Outstanding Research in CE 2018 Awards - ACEhp Alliance Industry Summit Best in Class Outcomes - ACEhp Award for Outstanding CE Outcomes Assessment 2017 Awards - ACEhp Alliance Industry Summit Best in Class Poster Recognition (X2) - ACEhp Award for Outstanding Innovation in Continuing Professional Development 2016 Awards - ACEhp Alliance Industry Summit Overall Best in Class QIE Outcomes - ACEhp Best in Class QIE Outcomes - ACEhp Grand Leadership Award - ACEhp SQUIRE Certificate of Excellence in Multidisciplinary Approach - ACEhp SQUIRE Certificate of Excellence in Outcomes and Design - ACEhp William Campbell Felch Award for Outstanding Research in CE - AMCP Managed Care and Specialty Pharmacy Poster Award
- Website
-
https://primece.com
External link for PRIME Education
- Industry
- Education
- Company size
- 51-200 employees
- Headquarters
- New York, NY
- Type
- Public Company
- Specialties
- Systems-Based Learning, Performance Improvement, Patient Engagement, Research, Public Health Priorities, Care Coordination, Quality Improvement, Continuing Medical Education, Continuing Education, and Implementation Science
Locations
-
Primary
Get directions
114 5th Ave.
14th Floor
New York, NY 10011, US
Employees at PRIME Education
-
Lynda Chiarella
Director of Marketing, PRIME Education - Digital Marketing Strategy
-
Emily Zyborowicz
Director, Education & Research Strategy at PRIME Education
-
Kelly Pillinger, PharmD, BCPS, BCIDP
Associate Director, Scientific Affairs (Infectious Diseases) at PRIME Education
-
Kelly Valla, PharmD, BCOP
Associate Director, Scientific Affairs - Oncology/Women’s Health at PRIME Education
Updates
-
Watch Now! | Transforming Multiple Myeloma Management: Key Strategies for Infectious Disease Teams Using Bispecific Antibodies | 0.25-hour CME/CE | On-Demand Video #3 of 4 | #MedEd #cme #MultipleMyeloma | https://bit.ly/3ZLZSJX
-
-
Fine-tune your approach for optimized treatment outcomes | Strategies for Monitoring and Optimizing Multiple Sclerosis Treatment Approaches | 0.75-hour CME/CE | On-Demand Video #3 of 4, MS Accelerator Hub | #MedEd #cme #MultipleSclerosisTreatment | https://bit.ly/3Y7JJ0l
-
-
Just Released! Maximizing Multiple Myeloma Care: What Hematology/Oncology Teams Need to Know About Bispecific Antibodies | 0.5-hour CME/CE | On-Demand Video #1 of 4 | #MedEd #cme #MultipleMyeloma | https://bit.ly/4f3LC3V
-
-
Take a curated, patient-centered approach | Tailoring Multiple Sclerosis Treatments Based on Clinical and Patient-Specific Factors | 0.5-hour CME/CE | On-Demand Video #2 of 4, MS Accelerator Hub | #MedEd #cme #MultipleSclerosisTreatment | https://bit.ly/3Y7Jp1D
-
-
Now Available! | Personalized Pathways for Managing Generalized Myasthenia Gravis: The Role of FcRn Antagonism | 0.5-hour CME/CE | On-Demand Video #2 of 2 in Learning Lab | #MedEd #cme #MyastheniaGravis #raredisease #MuscularDystrophy https://bit.ly/4f8GTyf
-
-
Recognize risk factors for AMKD and take action | Breaking Barriers in APOL1-Mediated Kidney Disease: Clinical Vigilance, Genetic Screening, and Emerging Treatments | 0.5-hour CME/CE | On-Demand Video | #MedEd #cme #KidneyDisease | https://bit.ly/3TNkQ7l
-
-
DDR-Mutated Breast Cancer: Get the latest data and strategies here | Optimizing Use of PARP Inhibitors in Early-Stage and Metastatic Breast Cancer Patients With DNA Damage Repair Pathway Mutations | #MedEd #cme #PARPinhibitors #breastcancer | https://bit.ly/4e9SqfI
-
-
Join us for this expert-led video and stay at the forefront | Navigating the Multiple Sclerosis Treatment Landscape: Incorporating New and Emerging Data Into Clinical Practice | 0.75-hour CME/CE | #MedEd #cme #MultipleSclerosisTreatment | https://bit.ly/3zMmkrR
-
-
Live Webinar on Dec 18th, Save Your Spot! Decoding Complex Chronic Lymphocytic Leukemia Cases: An Expert TheraTalk | 1-hour CME/CE | #MedEd #cme #livecredit #Leukemiatreatments | https://bit.ly/3CUS7YJ
-